This autonomy ??? which occurred in January 2011 ??? allows the Institute to continue to build its research programs and secure a broader range of grants and charitable gifts to support the development of new drugs and therapies to treat neurological disorders such as Alzheimer's Disease, head trauma, Gulf War Illness, Autism, drug addiction and Tourette's Syndrome.